Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction

By Dula E.   Keating W.   Siami P.F.   Edmonds A.   O'neil J.   Buttler S.  

Urology, Vol. 56, Iss. 1, 2000-07 ,pp. : 130-135

Elsevier

Access to resources Recommend Favorite

The Role of Apomorphine SL in the Treatment of Erectile Dysfunction

By Montorsi F.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 4-11

Elsevier

Access to resources Recommend Favorite

Recovery of erectile function by the oral administration of apomorphine

By Heaton J.P.W.   Morales A.   Adams M.A.   Johnston B.   El-Rashidy R.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 200-206

Elsevier

Access to resources Recommend Favorite

Apomorphine SL: Evolution of a Centrally Acting Treatment for Erectile Dysfunction

By Giuliano F.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Effects of Visual Sexual Stimuli and Apomorphine SL on Cerebral Activity in Men with Erectile Dysfunction

By Hagemann J.H.   Berding G.   Bergh S.   Sleep D.J.   Knapp W.H.   Jonas U.   Stief C.G.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 412-420

Elsevier

Access to resources Recommend Favorite